José Alberto Orfao de Matos Correia e Vale-rekin lankidetzan egindako argitalpenak (54)

2017

  1. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    Leukemia, Vol. 31, Núm. 10, pp. 2094-2103

2015

  1. Ex vivo identification and characterization of a population of CD13high CD105+ CD45- mesenchymal stem cells in human bone marrow

    Stem Cell Research and Therapy, Vol. 6, Núm. 1

2014

  1. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

    Leukemia

  2. Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene

    American Journal of Hematology, Vol. 89, Núm. 3, pp. 288-294

2012

  1. Bone marrow transplantation extends its scope

    Advances in Experimental Medicine and Biology, Vol. 741, pp. 121-134

2005

  1. Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: A comparison with their respective sibling donors

    Biology of Blood and Marrow Transplantation, Vol. 11, Núm. 5, pp. 354-361

  2. Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability

    Experimental Hematology, Vol. 33, Núm. 8, pp. 935-943

2004

  1. Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities

    Leukemia Research, Vol. 28, Núm. 11, pp. 1181-1187

  2. Impact of immunophenotype on prognosis of patients with myelodsyplastic syndromes. Its value in patients without karyotypic abnormalities

    Hematology Journal, Vol. 5, Núm. 3, pp. 227-233

2003

  1. Immunophenotypic analysis of myelodysplastic syndromes

    Haematologica, Vol. 88, Núm. 4, pp. 402-407

  2. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma

    Haematologica, Vol. 88, Núm. 9, pp. 1013-1021

  3. Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: Early immunophenotypic evaluation has high clinical value

    Blood, Vol. 101, Núm. 12, pp. 4695-4700

2001

  1. Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

    Blood, Vol. 98, Núm. 6, pp. 1746-1751

  2. Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells

    Journal of Biological Regulators and Homeostatic Agents, Vol. 15, Núm. 1, pp. 53-61

2000

  1. Cytogenetic abnormalities are associated with immunophenotypic changes in refractory anemias

    Blood, Vol. 96, Núm. 11 PART I

1999

  1. Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

    Bone Marrow Transplantation, Vol. 24, Núm. 12, pp. 1279-1283

  2. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705

  3. Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage- cells

    Clinical and Experimental Immunology, Vol. 118, Núm. 3, pp. 392-401

  4. Myelodysplastic syndrome: A search for minimal diagnostic criteria

    Leukemia Research, Vol. 23, Núm. 3, pp. 283-290

1998

  1. In vitro growth in acute myeloblastic leukaemia: Relationship with other clinico-biological characteristics of the disease

    British Journal of Haematology, Vol. 103, Núm. 1, pp. 137-142